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Editorial C o m m e n t , 
Starting w i t h V o l u m e 156, 1979, the name of the «Zeitschrift für 
Immunitätsforschung» has been changed to 
«Immunobiology » 
The «Zeitschrift», founded i n 1909 b y Paul E h r l i c h , was the f i rs t 
i m m u n o l o g i c a l journa l to be publ ished i n the w o r l d . The journa l has 
a long- l ived reputat ion as being an i m p o r t a n t source of scientific 
i n f o r m a t i o n based on the contr ibut ions of famous immunologis ts . 
The increased use of Engl ish as the c o m m o n scientific language has 
n o w p r o m p t e d the E d i t o r i a l Board to change the t radi t ional Ger-
m a n t i t le to « I m m u n o b i o l o g y » . W i t h this t i t le change the j o u r n a l 
emphasizes its internat ional character as a f o r u m f o r the publ i ca t ion 
of a variety of dif ferent articles i n the broad f ie ld of i m m u n o l o g y . 
The E d i t o r i a l Board of I m m u n o b i o l o g y 
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Abstract 
Cytotoxic T lymphocytes (CTL) f rom DBA/2 strain mice primed w i t h Sendai virus (SV) in 
vivo were activated by secondary stimulation of spleen cells w i t h viral antigens in vitro and 
analyzed for their target antigen specificity. These effector cells lysed syngeneic Sendai virus 
infected target cells, marginally a variety of non-infected targets and had a strong cytotoxic 
effect on H - 2 b targets. Studies on the antigenic requirements revealed that all SV preparations 
which generated specific C T L also induced the alloreactive populations. Similar results were 
found in the response to Newcastle disease virus ( N D V ) and some influenza A viruses; all 
these viruses were mitogenic for lymphocytes. Experiments on the cellular requirements 
indicated that virus specific and alloreactive cells can be separated by their requirements for 
help and for restimulation. By competition experiments both activities could be attributed to 
clearly separable T cell subpopulations. The induction mechanism of alloreactive T cells by 
viral antigens is discussed. 
Introduction 
H - 2 restricted cytotoxic T lymphocytes ( C T L ) are generally rather 
specific f o r the antigen and f o r the restrict ing H - 2 determinants. H o w e v e r , 
the d iscr iminatory capacity of these cytotoxic T cells is not absolute. 
Exceptions have been observed and fal l i n t o the f o l l o w i n g patterns: T N P -
specific C T L have exquisite antigen specificity (1) but their specificity f o r 
the restrict ing H - 2 antigens is less p r o m i n e n t . O n the other hand, the H - 2 
restr ict ion specificity of cytotoxic effector cells w i t h antigen specificity f o r 
viruses or m i n o r H-antigens is clearly demonstrable. T h e y do n o t lyse 
allogeneic target cells carrying the same vira l antigen (al though there is 
some crossreactivity between H - 2 k and H - 2 d ) and even have the capacity to 
differentiate between H - 2 mutants (2-4) . H o w e v e r , they show extensive 
crossreactivity o n target cells carry ing antigens of serological dist inct v i ra l 
substrains (5), they lyse syngeneic T N P m o d i f i e d target cells (6) and there is 
even cy to ly t i c act ivi ty o n allogeneic target cells w i t h o u t any m o d i f i c a t i o n 
b y virus or hapten (7, 8). 
Abbreviations: CTL = cytotoxic T lymphocytes; GM = growth medium; NDV = 
Newcastle disease virus; SV = Sendai virus. 
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Based o n the crossreactive patterns observed i t has been recently p r o -
posed that all alloreactive effector cells represent crossreactive cell popula -
tions w h i c h are generated i n the response to environmenta l antigens w h i c h 
elicit n o r m a l l y H - 2 restricted responses (9). I n this r e p o r t w e describe the 
generation of alloreactive T effector cells i n the response to three antigeni-
cally unrelated viruses. Splenic lymphocytes f r o m D B A / 2 strain mice 
generate u p o n virus specific res t imulat ion i n v i t r o alloreactive cytotoxic T 
cells w h i c h lyse u n m o d i f i e d H - 2 b target cells. Studies o n the i n d u c t i o n 
mechanism and c o m p e t i t i o n experiments demonstrate that these effector 
cells represent separate subsets of C T L w i t h selective specif ic i ty f o r H - 2 K b 
or H - 2 D b . 
Materials and Methods 
Animals: Mice from the strains DBA/2, BALB/c, B10.D2, B10.BR, C B A , B10.S, BIO, 
B10.A(2R), B10.A(5) and SWR were raised in our own breeding facility and used at 6-10 
weeks of age. 
Viruses: Sendai virus and influenza A/Victoria virus (H3N2) were propagated, titrated, 
purified and inactivated as described (10). Newcastle disease virus strain Italien ( N D V ) and the 
influenza virus strains APR/8 ( H O N 1 ) , A/USSR (H1N1) and A/ASIA ( H 2 N 2 ) were kindly 
supplied by Drs. Klenk and Rott, Gießen, ß-propiolactone inactivated Sendai virus (ß-pl-SV) 
(2 mg in 1 ml of the appropriate buffer) was digested w i t h proteolytic enzymes as described 
previously (11). Trypsin treatment (8 ul , 5 mg/ml; TPCK-treated, Worthington) was for 1 h at 
37 °C in 0.5 % ammonium bicarbonate buffer, p H 8. Treatment w i t h V8 protease from 
Staphylococcus aureus: (50 ul , 1 mg/ml; Miles) for 18 h at 37 °C in 50 m M ammonium 
bicarbonate buffer p H 8. Sendai virus preparations were kindly provided by D r . M . J. 
Gething, ICRF, London, U K . 
The capacity of the virus preparations to induce target cell formation was measured in the 
cytolytic assay (11, 12). Haemagglutinin, neuraminidase, haemolytic activities and cell fusion 
were tested as described previously. As reported in Reference 11 virus preparations treated 
with trypsin (TRY-SV) had haemagglutination and neuraminidase activities comparable to ß-
pl-SV, but lacked the fusion capacity and the haemolytic activity (F"). The preparation digested 
wi th V8 protease from Staphylococcus aureus (V8-SA-SV) still contained the F glycoprotein 
but the haemagglutinin-neuraminidase glycoprotein spikes were removed from the virion 
( H A N A - ) . 
Immunizations: Mice were injected once i.p. w i t h 100 haemaglutination units ( H A U ) of 
infectious virus. 3-10 weeks afterwards spleens were removed and lymphocytes were prepared 
for tissue culture. 
Media: Cells were cultured in RPMI1640 medium with L-glutamine (2 m M final concentra-
tion) streptomycin and penicillin (50 units/ml), 2-mercaptoethanol (2 X 10"° M ) and 10% fetal 
calf serum. 
Cell cultures: P-815 (H-2 d ) RBL5 (H-2 b ) and A K R A (H-2 k ) tumor cells were grown in vitro 
at a concentration of 2 X 105 cells/ml w i t h medium change after every 48 hrs. Mouse spleen 
cells or lymph node cells were suspended in medium at a concentration of 4 X 10 6 cells/ml. 
Cells were cultured in multi-dish culture trays (FB-24 Tc, Linbro Chemicals, N e w Haven, 
Conn., USA) or in plastic tissue culture flask of different sizes. If desired, cells were depleted 
from erythrocytes by lysis in 0.184 M N H 4 C 1 or by separation on a Ficoll-Hypaque gradient. 
Growth medium: DBA/2 spleen cells (4 X 106/ml) were plated in mul t i dish trays and 
incubated for 48 hrs in the presence of 10 ,ug/ml concanavalin A (Pharmacia Uppsala, Sweden). 
After incubation the supernatant was harvested, centrifuged at 900 g for 10 min . , filtered 
through a 0.45 UJTI filter (Gelman, A n n Arbor , Mich . , USA) aliquoted and stored at -20 °C. 
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Growth medium was added to long term cultures in a 1:2 dilution with fresh complete 
medium. Cells in growth medium were seeded at a concentration of 2 X lOYml and were split 
when the cell concentration reached 0.5 X 106/ml or routinely after 4 days. 
Helper cell culture conditions: Helper cells were generated by first step cultures in a 
modification of the protocol described by Baum and Pikrski (13). Helper cells were activated 
either specifically by viral antigens or alloantigens, or received no antigen. Helper cells 
obtained from a 1 day or 2 day first culture period were transferred into a second step culture 
to help a cytotoxic response by thymocyte killer precursors. Helper cells were irradiated with 
1500 rad before addition to the thymocyte cultures. Controls included: 1. Thymocytes 
cocultured with irradiated helper cells in absence of viral antigens, 2. Irradiated helper cells in 
presence of viral antigens, 3. Thymocytes in presence of viral antigens in absence of helper 
cells. These controls were negative. Cytotoxic T cells were assayed at day 5 of the secondary 
culture. 
5 1 Cr-release assay: The conditions of the 5'Cr-release assay and calculation of data are 
described in a previous paper (10). AH values are the mean percent specific MCr-release of 
triplicate wells. The standard errors of the means were always less than ± 5% and are omitted 
from figures and tables for clarity. 
Results 
Virus specific activated lymphocytes are cytotoxic for non-infected 
allogeneic target cells 
Spleen cells f r o m D B A / 2 mice p r i m e d to Sendai virus were specifically 
rest imulated i n v i t r o and tested i n the 5 1 Cr-release assay o n various target 
cells (Fig . 1). D a t a show that a strong cytotoxic response was generated 
w h i c h c o u l d be demonstrated b y the lysis of Sendai virus infected syngeneic 
D B A / 2 - S V 
I T I I 
20 10 5 2.b 
D B A / 2 C3H BIO. A C 5 7 B I 6 
\ 
P - 8 1 5 A K R - A 
\ 
\ 
R B L - 5 
K : T r a t i o 
Fig. 1. DBA/2 spleen cells challenged with Sendai virus lyse non-infected allogeneic cells 
Responder cells are derived from DBA/2 strain mice primed with infectious virus 3 weeks 
previously. Targets are con A blast cells incubated with 10 ug SV antigen for 1 hr at 37 °C or 
tumor cells p-815 (H-2 d ) , A K R - A (H-2 k ) and R B L - 5 (H-2 b ) prepared similarly. Assay time 
4 hrs. 
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Table 1 . Generation of alloreactive cytolytic activity for H - 2 b targets by SV in different mouse 
strains 
TARGETS 
Mouse strain 3) Haplotype % specific 5 1 Cr release*3) 
syngeneic SV infected RBL-5 
blast cells 
DBA/2 H - 2 d 73 52 
B 10.D2 H - 2 d 51 24 
Balb/c H - 2 d 44 13 
CBA H - 2 k 40 6 
B 10.BR H - 2 k 47 9 
B 10. H - 2 b 38 -2 
B 10.S H - 2 S 35 3 
SWR H-2*» 48 5 
a ) Responders were primed in vitro wi th SV in vivo and restimulated in vitro wi th 1 ug/ml SV 
antigen. 
b ) K : T ratio 20:1 
con A blasts w h i l e non- infected syngeneic target cells were n o t lysed. W h e n 
tested o n semiallogeneic or allogeneic target cells various degrees of c y t o l y -
sis were observed. W h i l e there was o n l y marginal lysis o n H - 2 k and H - 2 a 
target cells H - 2 b blasts were lysed w i t h an efficiency comparable to the lysis 
of virus infected syngeneic target cells. T u m o r target cells of haplotype H -
2 b o n l y were s imi lar ly lysed w h e n act ivi ty o n t u m o r cells of the haplotypes 
H - 2 d (P-815), H - 2 k ( A K R - A ) and H - 2 b (RBL-5 ) were compared. B o t h 
infected and non-infected H - 2 b target cells were lysed to the same extent 
(not shown) . I n c o n t r o l spleen cell cultures w i t h o u t Sendai virus antigens 
neither virus specific nor alloreactive cytotoxic act ivi ty was generated. 
The capacity of Sendai virus to generate alloreactive cytotoxic act ivi ty 
was n o t restricted to the D B A / 2 strain mice. W h e n mice of the strains 
B10 .D2, B A L B / c , D B A / 2 , B10.BR, BIO and SWR were tested (Table 1), i t 
was f o u n d that in all H - 2 d strain mice some cytotoxic act ivi ty w i t h 
specificity f o r H - 2 b targets was generated w h i c h was n o t f o u n d i n the other 
strains tested. The cytotoxic act iv i ty on H - 2 b target cells could be abrogated 
b y the treatment of effector cells w i t h a n t i - T h y 1.2 serum and complement 
or a n t i - L y t 2.3 serum and complement indicat ing the T cell nature of the 
alloreactive cell p o p u l a t i o n (data n o t shown) . 
Induction requirements of alloreactive cytolytic T cells following virus 
specific restim ulation 
A ) Viral antigen requirements 
D B A / 2 mice p r i m e d to an o r t h o m y x o v i r u s ( influenza A/Vic tor ia 
[ H 3 N 2 ] ) or paramyxoviruses (Sendai v i rus , Newcastle disease virus 
[ N D V ] ) were restimulated w i t h the sensitizing v i rus . I n the case of N D V 
and A / V i c t o r i a infective virus f r o m allantoic f l u i d was used as antigen. F o r 
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Sendai virus specific rest imulat ion i n this experiment, p u r i f i e d non-infec-
tious virus was employed. A part of the SV preparat ion was treated w i t h 
t r y p s i n to destroy the funct ional act ivi ty of the fus ion p r o t e i n , w h i l e 
another preparation lacked the haemagglutinin-neuraminidase p r o t e i n , f o l -
l o w i n g V 8 protease treatment. The results of Figure 2 show that n o n -
infectious Sendai virus was also able to generate the alloreactive C T L 
p o p u l a t i o n and inact ivat ion of the F p r o t e i n or removal of the H N p r o t e i n 
was of l i t t l e effect. Fur thermore , i t is depicted that generation of N D V 
specific C T L was also accompanied b y generation of an H - 2 b specific 
act iv i ty , w h i l e an H 3 N 2 subtype of influenza A generated specific C T L 
w h i c h d i d n o t contain H - 2 b specific alloreactive cells. 
Recently B U T C H K O et al. (14) reported that H 2 N 2 subtypes of influenza 
A viruses are mitogenic f o r lymphocytes . This effect could be a t t r ibuted to 
the haemagglutinin of type 2. Since i n our hands ( U . K . , unpubl ished) the 
glycoproteins of paramyxoviruses are also mitogenic f o r lymphocytes , we 
tested to see i f inf luenza A strains of H 2 N 2 subtype w o u l d also give rise to 
alloreactive C T L . F o u r influenza A strains d i f fe r ing w i t h respect to 
haemagglutinin and neuraminidase type were used f o r i n v i t r o p r i m i n g and 
f o r secondary s t imula t ion of C T L i n v i t r o . Effector cells were tested o n 
virus infected and non-infected target cells and i n addi t ion o n non-infected 
H - 2 b targets. As publ ished b y other authors (5) lysis of infected cells was 
specific f o r or thomyxoviruses b u t cross-reactive f o r the different influenza 
A subtypes (data n o t shown) . W h e n tested o n H - 2 b target cells (Table 2) 
o n l y , the H 2 N 2 subtype was active i n generation of alloreactive cy to ly t i c 
act iv i ty . H o w e v e r , to give rise to a s trong effect o n H - 2 b target cells i n v i v o 
p r i m i n g w i t h the H 2 N 2 subtype was required. A l s o , i n secondary st imula-
D B A / 2 S V p r i m e d 
B - p l - S V T R Y - S V S A - S V 
D B A / 2 N D V p r i m e d D B A / 2 I N F L . p r i m 
N D V 
P - 8 1 5 o P - 8 1 5 - S V O P - 8 1 5 - f 
I N F L , A ( H 3 N 2 ) 
P - 8 1 5 - I N F L . • R B L - 5 
f f 
20 10 
K : T r a t i o 
Fig. 2. Antigenic requirements for CTL activation 
R = responder cells; S = stimulator cells; T = target cells; N D V = Newcastle disease virus, 
strain Italien; I N F L = Influenza A virus, strain Victoria (H3N2) . 
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Table 2. Lysis of RBL-5 ( H - 2 b ) tumor cells by influenza A virus specific activated DBA/2 
spleen cells 
Viruses used for in vivo Viruses used for restimulation in vi tro b ) 
priming 3 ) A/PR/8 A/USSR A/ASIA A / V I C T O R I A 
A/PR/8 (HO N l ) 4.99 11.82 3.42 -2.96 
A/USSR ( H I N l ) -2.38 5.79 7.43 1.40 
A/ASIA (H2 N2) 12.80 13.70 82.91 29.37 
A / V I C T O R I A (H3 N2) -1.26 0.68 -3.72 1.73 
a ) DBA/2 mice were primed with 100 H A U infective virus containing allantoic f luid at least 3 
weeks previous to secondary stimulation in vitro. 
b ) Cytotoxic test on day 6 of in vitro culture; K : T ratio 10:1, incubation time 4 hrs 
t i o n the other subtypes ( H 0 N 1 ) , ( N 1 N 1 ) and ( H 3 N 2 ) were active b u t the 
most effective response was again induced b y challenge w i t h the H 2 N 2 
subtype. Thus , the experiments o n antigenic requirements f o r generation of 
the alloantigen-specific act ivi ty revealed that a) dif ferent mitogenic viruses 
and b) the same antigenic preparations of Sendai virus w h i c h give rise to 
H - 2 restricted k i l l e r cells w i l l also generate effector cells w h i c h lyse H - 2 b 
target cells. 
B) Cellular requirements 
I n previous experiments we had f o u n d that virus specific cy totox ic 
effector cells could also be generated f r o m thymocytes i f antigen p r i m e d 
irradiated spleen cells were present i n the culture. For i n d u c t i o n of effector 
cells f r o m thymocytes the experimental p r o t o c o l described b y B A U M and 
P l L A R S K I (13) was applied. Three types of cell preparat ion w i t h helper cell 
f u n c t i o n were prepared: A ) D B A / 2 spleen cells st imulated w i t h Sendai 
virus , B) D B A / 2 spleen cells st imulated w i t h alloantigen (B10.BR, H - 2 k ) or 
C) D B A / 2 spleen cells w i t h o u t antigenic s t imula t ion . Cells f r o m type A , B 
or C were irradiated after 24 or 48 hrs i n tissue culture and 1 X 10 s of these 
helper cells were added to the cultures containing 1 X 10 8 thymocytes f r o m 
n o n - p r i m e d D B A / 2 mice and 1 (ig/ml Sendai virus antigen. The act ivi ty 
w h i c h was generated after 5 days of i n v i t r o culture was tested o n infected 
and non- infected syngeneic as w e l l as on allogeneic target cells. I t was f o u n d 
(Figure 3 A 1-3) that i n the presence of the irradiated cul tured cells A , B and 
C preincubated f o r 24 hrs, b o t h syngeneic virus specific act ivi ty and 
alloreactive act ivi ty was expressed. H o w e v e r , there was no c y t o l y t i c activ-
i t y generated w i t h o u t helper cells present i n the culture (Figure 3 A , 4) and 
the effector cells were generated f r o m thymocytes and n o t f r o m the helper 
cell f rac t ion (Figure 3 A , 5). A f t e r preincubat ion of helper cells f o r 48 hrs 
previous to the addi t ion of thymocytes different results were obtained 
(Figure 3B). U n d e r these condit ions effector cell populat ions were obtained 
f r o m thymocytes w h i c h had alloreactive cy to ly t i c act ivi ty o n l y w h i l e there 
was no generation of virus specific effector cells. This indicates that the 
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20 10 5 2.5 
K : T r a t i o 
Fig. 3. A 
H = helper cells, 1500 r irradiated 24 hrs preincubated; A = normal DBA/2 spleen cells 
preincubated with Sendai virus; B = normal DBA/2 spleen cells preincubated with B10.BR 
spleen cells; C = normal BBA/2 spleen cells preincubated without antigens added; 4 = no 
helper cells added to thymocyte responder cultures; 5 = no thymocytes added to helper cell 
cultures. 
B 
same helper cells incubated for 48 hrs 
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generation of virus specific C T L and alloreactive C T L i n the presence of 
Sendai virus can be separated b y their di f ferent requirements f o r help. 
T i t r a t i o n experiments carried o u t i n order to define the quanti tat ive 
requirements f o r helper cells (data n o t shown) also indicated that the 
generation of alloreactive C T L required smaller numbers of helper cells. 
H-2 restricted virus specific CTL and alloreactive CTL are different T cell 
clones 
A) Competition assays 
The results of the helper cell experiments already indicated that v irus 
specific and alloreactive cytotoxic act ivi ty reside i n dif ferent T cell subsets. 
B y compet i t ion experiments the specificity of the effector cells generated 
was evaluated. Sendai virus specific C T L f r o m the strain D B A / 2 were 
incubated w i t h 5 1 C r labelled SV infected con A blasts of the strain BIO ( H -
2 b ) . The addi t ion of various non-labelled i n h i b i t o r cells (SV infected con A 
blasts of the strain B10 .D2 and non-infected con A blasts of the strains 
B10 .D2, B10.BR, BIO, B10 .A(2R) and B10.A(5R) showed that i n h i b i t i o n of 
lysis could o n l y be obtained b y addi t ion of compet i tor cells carry ing H - 2 b 
antigens, w h i l e there was no i n h i b i t i o n of alloreactive k i l l e r act iv i ty b y 
addi t ion of n o r m a l or infected syngeneic cells or b y addi t ion of n o n -
infected allogeneic cells of other haplotypes (Figure 4, 2). S imilar ly , w h e n 
tested o n 5 l C r labelled B10 .D2 blasts infected w i t h Sendai virus , o n l y H - 2 d 
compet i tor cells infected w i t h Sendai virus were able to i n h i b i t the lysis of 
labelled target cells (Figure 4, 1). Thus , separate T cell subsets were 






T 1 1 1 r -
0 5 1 0 2 0 4 0 
R a t i o C o m p e t i t o r : T a r g e t s 
Fig. 4. Definition of effector cell specificity in competition experiments. 
Responder cells: DBA/2 spleen cells after secondary stimulation in vitro. Responder: target 
cell ratio 12.5:1. * no competitors added. 
Competitors (con A blasts): • B10.D2-SV O B10.D2, • B10.BR, O BIO, A B10.A (2R) ( K k , 
D b ) , V B10.A (5R) ( K b , D d ) . 
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generated i n the response to Sendai v i rus . O n e subset reacted o n l y w i t h 
syngeneic Sendai virus infected targets w h i l e the specificity of the other 
subsets was exclusively directed to H - 2 b alloantigens and d i d n o t cross-react 
w i t h antigens induced b y Sendai virus i n syngeneic cells. W e t r ied to map 
the target antigen(s) recognized b y the alloreactive C T L . The T cell subset 
w i t h al loreactivity f o r H - 2 b could be fur ther subdivided i n t o at least t w o 
clones, one very l i k e l y specific f o r H - 2 K b and the other f o r H - 2 D b as 
s h o w n b y fur ther c o m p e t i t i o n experiments (Figure 4,3, 4,4). 
B) Long term culture conditions 
L o n g t e r m tissue cultures (15-18) were set u p i n order to f i n d out i f b o t h 
populat ions have similar antigen rest imulat ion requirements. Cultures f r o m 
antigen p r i m e d mice were incubated w i t h Sendai virus i n order to generate 
virus specific effector cells. I n the same cultures cy to ly t i c activities specific 
for Sendai and f o r H - 2 b targets was generated. A f t e r 14-18 days i n v i t r o the 
cy to ly t i c act ivity o n b o t h targets started to cease. T o these cultures i r r a d i -
ated syngeneic s t imulator cells coated w i t h Sendai virus were added i n order 
to generate ter t iary cytotoxic effector cells. 6 days after rest imulat ion 
cytotoxic act ivi ty against syngeneic infected target cells could be d e m o n -
strated (Table 3, Exp . A ) w h i l e the c y t o l y t i c act ivi ty o n allogeneic target 
cells remained l o w ; yet, the potent ia l to generate alloreactive act ivi ty was 
not lost d u r i n g l o n g term culture. Cells f r o m cultures w h i c h previously had 
demonstrable c y t o l y t i c act ivi ty o n H - 2 b target cells were kept i n culture 
Table 3. Effect of long term tissue culture conditions on alloreactive and virus-specific 
cytotoxic T cells 
Exp. Day of in vitro1) Treatment of cultures K : T Target cells 
culture ratio (% 5 1 C r release) 
P-815 P-815-SV R B L - 5 
A 5 test 5:1 4 56 24 
14 test 5:1 3 30 2 
14 3° restimulation with SV 
infected spleen cells 
20 test 5:1 13 87 8 
B 18 test 5:1 3 26 40 
20 3°restimulation with SV 
infected spleen cells 
25 5:1 0 55 48 
32 test and splitting of cultures 5:1 0 6 n.t. 
35 test 5:1 0 0 2 
32 transfer into growth medium 
35 test 5:1 15 95 80 
a) DBA/2 spleen cells challenged in vitro with Sendai virus. For restimulation cells were 
transferred into fresh complete medium. In Exp. B at day 32 cultures were split and 50% of 
the cells were transferred into medium supplied with con A induced growth medium. 
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u n t i l all cy to ly t i c act ivi ty had ceased (Table 3, Exp . B) . U p o n transfer i n t o 
tissue culture m e d i u m enriched w i t h g r o w t h m e d i u m w i t h o u t any a d d i -
t ional specific antigenic st imulus b o t h alloreactive and H-2-res tr ic ted v i rus 
specific c y t o l y t i c act ivi ty was restored. Therefore, the alloreactive T cells 
remained present under l o n g te rm culture condit ions a l though they were 
refractory to the antigenic st imulus b y Sendai virus m o d i f i e d s t imulator 
cells indicat ing different rest imulat ion requirements of b o t h cy to ly t i c T cell 
populat ions . 
Discussion 
Data show that paramyxoviruses and influenza virus strains of the H 2 N 2 
subtype induce i n H - 2 d strain mice T effector cells w h i c h lyse syngeneic 
virus infected target cells and non-infected target cells carrying the 
haplotype H - 2 b . The alloreactive c y t o l y t i c act ivi ty can be induced w i t h 
infective inf luenza virus , Newcastle disease virus ( N D V ) and Sendai virus 
(SV). U s i n g SV non-infect ious virus preparations, v i r ions devoid of specific 
glycoproteins and vir ions carrying func t iona l ly inactivated glycoproteins 
were effective. These i n d u c t i o n condit ions are identical to that of v irus 
specific effector cells w h i c h recognize paramyxovirus antigens o n target 
cells ( t ) . Viruses w h i c h were able to generate al loreactivity had mitogenic 
effects o n lymphocytes . 
The alloreactive cell p o p u l a t i o n w i t h c y t o l y t i c efficiency comparable to 
that of the virus specific H - 2 restricted effector cells resides i n a separate 
effector cell subset. This is revealed b y a) dif ferent antigen specificity i n co ld 
target cell i n h i b i t i o n tests b) di f ferent requirements f o r help d u r i n g i n d u c -
t i o n and c) dif ferent requirements f o r rest imulat ion under l o n g term i n v i t r o 
culture condit ions . Al together we report that alloreactive C T L w i t h o u t 
crossreactive cy to ly t i c act ivi ty o n virus infected target cells are generated 
f r o m spleen cells i n v i t r o u p o n antigenic s t imulat ion b y v ira l antigens. 
I t has been s h o w n b y several authors that m u r i n e spleen cells st imulated 
b y antigens w h i c h induce a H - 2 restricted response contain C T L , w i t h 
specificity for the sensitizing antigens, but also addit ional effector p o p u l a -
tions w h i c h recognize unrelated antigenic determinants (5-9, 18). Since the 
specificity of the i m m u n e repertoire is l i k e l y to be defined b y various 
degrees of affinities rather than b y subsets of non-over lapping specificity 
some crossreactivity was to be expected. The T cell subsets w i t h addit ional 
reactivity described so far were defined b y c loning of effector cells (8, 18) or 
b y c o m p e t i t i o n studies w i t h non-label led target cells (6, 9). These studies 
revealed that those effector cells were crossreactive i.e. the same T cell 
clones seemed to carry receptors specific f o r the syngeneic antigen-expres-
( , ) K O S Z I N O W S K I , U . , and M . J . G E T H I N G . Generation of virus specific cytotoxic T cells in 
vitro. I I . Induction requirements w i t h functionally inactivated virus preparations (submitted 
for publication). 
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sing target cells as w e l l as f o r allogeneic targets. This indicates that 
molecules expressed o n allogeneic targets may have antigenic determinants 
w h i c h the virusspecific effector cell cannot discriminate f r o m determinants 
brought about b y the antigen specific m o d i f i c a t i o n of syngeneic target cells. 
Does the interpretat ion that the i n d u c t i o n of the alloreactive T cell clones 
b y viruses is antigen specific and that some sharing of antigenic determi-
nants must exist even w h e n the relatedness is n o t demonstrable at the 
effector cell stage also apply to our findings? O n e possibi l i ty may be that 
the a f f i n i t y f o r the shared determinants induced b y the virus is h i g h d u r i n g 
i n d u c t i o n and l o w at the effector cell level. This is indicated b y recent data 
of B A K E R et al. (18). The i r effector cell populat ions were induced against 
allogeneic cells but showed crossreactivity o n syngeneic target cells. C l o n -
i n g revealed effector cell clones of all three possible specificities: clones w i t h 
specificity f o r the alloantigen o n l y , crossreactivity cells and cells w i t h 
selective specificity f o r syngeneic cells. I f the crossreactive clones had arisen 
b y antigen specific i n d u c t i o n i t is u n l i k e l y that o n l y clones w i t h exquisite 
specificity f o r syngeneic determinants were induced b y non-antigens 
specific mechanism. Fur thermore , other authors have s h o w n i n activation 
protocols similar to ours (9) that Sendai virus can i n fact induce crossreac-
tive effector cells w i t h specificity f o r alloantigens and also f o r v i ra l antigens 
o n target cells. W e cannot exclude that i n our cell cultures, also, some 
crossreactive act ivi ty m i g h t have arisen. I f so i t was too small to be detected 
b y the compet i t ion assays. H o w e v e r , i t is d i f f i c u l t to envisage h o w the three 
viruses w h i c h neither serologically n o r o n the T effector cell level show 
antigenic crossreactivity all share determinants w i t h H - 2 b . 
A n o t h e r possibi l i ty w h i c h can be advanced to explain the generation of 
alloreactive clones i n virus specific T cell activation is the i n d u c t i o n of 
unrelated t h i r d par ty antigenic determinants b y virus . I n this case o n l y the 
immunogenic presentation of determinants is a feature specific f o r some 
viruses; not , however, the antigens themselves. The antigens may be 
derepressed endogenous vira l antigens (19, 20) or cell surface antigens 
(21-23). The failure of the rest imulat ion of the alloreactive clones b y virus 
i n the long te rm cultures could be explained b y such mechanisms. Cells 
capable of expressing relevant antigenic determinants or regulatory T cells 
required f o r rest imulat ion to that antigen may n o t be present under those 
condit ions. 
Since a) the alloreactive effector cell p o p u l a t i o n does n o t show any 
a f f in i ty f o r determinants induced b y the sensitizing antigen w h i c h are 
recognizable b y virus specific effector cells and b) antigenically unrelated 
viruses give rise to similar effector cell populat ions , i t is l i k e l y that the lack 
of a f f in i ty at the effector cell level reflects i n d u c t i o n b y non-ant igen specific 
mechanisms. B E V A N et al. (24) observed that concanavalin A induced in 
spleen cells f r o m H - 2 d strain mice the generation of alloreactive effector 
cells w i t h specificity f o r H - 2 b . H o w e v e r , the p o l y c l o n a l act ivation generates 
T cells of 10-100 f o l d less act ivi ty than w e f i n d b y s t imulat ion w i t h v ira l 
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antigens, a l though the mitogenic effect of paramyxoviruses is l o w . 
Inf luenza viruses of the subtype H 2 N 2 have been reported to have 
mitogenic activities (14), I n our experiments the very same subtype induces 
alloreactive cy to ly t i c act ivi ty . Thus , the pro l i f e ra t ion data can n o w be 
l inked f o r the f i rs t t ime w i t h a T cell f u n c t i o n . T h e effect differs , however , 
f r o m effector cells generated b y con A , since i n v i v o p r i m i n g and i n v i t r o 
rest imulat ion is required. I f the process of activation is n o t antigen specific 
i t is necessary to explain the strong response towards the H - 2 d target. 
Fur ther experiments are required to define i f there is a predominant 
activation of C T L precursors specific f o r H - 2 b or i f D B A / 2 mice have a 
h i g h frequency of precursor T cells f o r this alloantigen. 
I t has been argued that al l alloreactive T cells are crossreactive cell 
populat ions induced b y environmental antigens (9). O u r data seem to 
extend these observations i n showing that v i ra l antigens can even induce 
effector cells w i t h selective specificity o n l y f o r the alloantigen. H o w e v e r , 
we feel that the capacity of some viruses to trigger alloreactive cell clones 
does not necessarily indicate that this effect accounts f o r the presence of the 
large number of alloreactive T cell precursors. 
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